Recent Updates

Modified on: 
Aug 27, 2021

The Public Education and Awareness Committee (PEAC) facilitates interprovincial collaboration in the development and implementation of public education and awareness strategies. Organ donation and transplantation is complex and not well understood by the public. There are many misconceptions that contribute to barriers to registering intent to donate or consenting to donation.

Organs and Tissues
Modified on: 
Aug 27, 2021

This annual report describes surveillance of transmissible blood-borne infections and emerging threats of concern. High quality and timely surveillance is central to the safety of the blood supply. This includes monitoring of transmissible disease markers that the blood is tested for and investigation of any reports of possible transfusion transmission, as well as a horizon scan for any new pathogens that may pose a risk. Non-infectious surveillance of aspects of donor health and safety as well as diagnostic services are also included.

Transfusion
Modified on: 
Aug 23, 2021

The Liver Transplant Advisory Committee (LTAC) advises on inter-provincial operational and clinical policies, standards of practice and evidence-based practice with respect to liver listing and allocation.

Members

Organization

Dr. Susan Gilmour (Chair)

Regional Program Clinical Director AHS - Stollery Children's Hospital

Organs and Tissues
Modified on: 
Aug 3, 2021

This interactive online platform reports national performance data for organ donation and transplantation in Canada. The dashboard consists of nine primary sections presenting data on key aspects of the donation and transplantation across the system. The data presented here are results as of Dec. 31, 2020.

Organs and Tissues
Modified on: 
Jul 28, 2021

Author: Matthew Yan, MD, FRCPC
Publication date: January 2020
Primary target audience: health-care professionals working in hospitals in Canada, excluding Quebec

 

Transfusion
Modified on: 
Jul 27, 2021

All blood transfused in Canada is collected from volunteer donors. To ensure the safety of blood components, donors are carefully screened. In addition, the donated blood is tested to identify blood group, blood group antibodies and transfusion-transmissible pathogens. Donor eligibility criteria and testing also benefit the donors by reducing potential blood donation-related health risks.

This chapter describes the donor selection process, the testing done on donated blood, and the pathogen inactivation processes that can further reduce risk of transfusion-transmitted diseases. This chapter is complemented by Chapter 7, Fractionated Blood products and Associated Pathogen Safety, and Chapter 8, Pre-transfusion Testing, of this Guide.

Transfusion
Modified on: 
Jul 22, 2021

The CTR team at Canadian Blood Services strives to ensure optimal functionality of the Canadian Transplant Registry. If you have any questions regarding a release, or would like to report an issue with the Canadian Transplant Registry, please do not hesitate to contact us. Email: transplantregistry@blood.ca

Organs and Tissues
Modified on: 
Jul 20, 2021

Key Points

  • Severe allergic or anaphylactic reactions are reported in 1.2 to 5.9 per 100,000 components transfused. The most recent Canadian Blood Services surveillance data on allergic reactions is available in the annual surveillance report.
  • There are various mechanisms that can lead to anaphylactic or severe allergic reactions, and some may not be preventable despite product modification.
  • Even in the presence of low anti-IgA level and anti-IgA antibodies, risk of anaphylactic transfusion is low.
  • Anti-IgA testing is only recommended in selected individuals with history of one anaphylactic transfusion reaction or two severe allergic transfusion reactions.
  • The form for ordering anti-IgA testing can be found on the Canadian Blood Services website.
  • Instructions and guidance on how to report adverse transfusion reactions can be found in this guide on the Canadian Blood Services Professional Education website.
Transfusion
Modified on: 
Jun 30, 2021

Blood transfusion is a crucial component of medical therapy today. Having a resilient blood system that can withstand widespread crises, such as pandemics, is an important feature of a sustainable blood supply.1 Pandemics are a sustained disaster with significant impact on the supply of labile components (e.g., red blood cells, platelets, plasma) and non-labile products (e.g., immune globulins). SARS-CoV-2, the virus responsible for COVID-19 illness, is not transmissible by blood (see Canadian Blood Service’s COVID-19 FAQ for health professionals working with blood products). However, COVID-19 had an impact on donor eligibility, donor availability, and availability of trained personnel to collect and produce blood products.2,3

Transfusion
Modified on: 
Jun 22, 2021

The Kidney Transplant Advisory Committee (KTAC) provides expert guidance to the development, operation and evolution of the national Kidney Paired Donation (KPD) program and Highly Sensitized Patient program (HSP) with the goal of increasing kidney transplantation in Canada. The KTAC also reviews proposed matches from each KPD match run.

 

Members

Organs and Tissues

Pages